There is some promising research results for treatment of patients with traumatic brain injury. Treatment for Traumatic Brain Injury (TBI) is often elusive. While it's a major cause of disability and death, finding treatment with medications has generally failed. A new study found that memantine, a drug that is used to treat dementia associated with Alzheimer's disease, may be a promising therapy.
The study examined the effect of the drug on blood levels of neuronspecific enolase (NSE), a marker of neuronal damage. The blood level was significantly reduced by day 7 of treatment.
In addition, the Glasgow Coma Scale (GCS) is commonly used after a brain injury to describe the level of consciousness in a person following a traumatic brain injury. There were marked improvements in traumatic brain injury patients GCS by day 3 of treatment in the study.